PatientsVille.com Logo

PatientsVille

Errin Side Effects

Common Errin Side Effects


The most commonly reported Errin side effects (click to view or check a box to report):

Anxiety (3)
Depression (3)
Cerebrovascular Accident (2)
Deep Vein Thrombosis (2)
Headache (2)
Pain (2)
Pregnancy On Oral Contraceptive (1)
Neck Pain (1)
Paraesthesia (1)
Type 1 Diabetes Mellitus (1)
Influenza (1)
Vertigo (1)
Weight Decreased (1)
Musculoskeletal Chest Pain (1)
Myocardial Infarction (1)
Nausea (1)
Musculoskeletal Pain (1)
Jaundice (1)
Intentional Self-injury (1)
Injury (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Errin Side Effects Reported to FDA

The following Errin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Errin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Anxiety, Gallbladder Disorder, Pain, Pulmonary Embolism, Cerebrovascular Accident, Depression, Myocardial Infarction, Deep Vein Thrombosis
This is a report of a 30-year-old female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Errin (dosage: Unk, start time: Mar 10, 2010), combined with:
  • Nexium (40 Mg, Qd)
  • Vicodin
  • Drospirenone And Ethinyl Estradiol
  • Elmiron (100 Mg, Tid)
  • Hydrocodone Bitartrate (500 Mg, Prn)
  • Zantac (Unk)
  • Cymbalta (60 Mg, Qd)
  • Drospirenone And Ethinyl Estradiol (Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Anxiety
  • Gallbladder Disorder
  • Pain
  • Pulmonary Embolism
  • Cerebrovascular Accident
  • Depression
  • Myocardial Infarction
  • Deep Vein Thrombosis
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Errin treatment in female patients, resulting in anxiety side effect. The patient was hospitalized.

Injury, Anxiety, Cholelithiasis, Anhedonia, Pain, Cholecystectomy, Emotional Distress
This report suggests a potential Errin Injury, Anxiety, Cholelithiasis, Anhedonia, Pain, Cholecystectomy, Emotional Distress side effect(s) that can have serious consequences. A 26-year-old female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: NA and used Errin (dosage: Unk) starting Jan 01, 2009. Soon after starting Errin the patient began experiencing various side effects, including:
  • Injury
  • Anxiety
  • Cholelithiasis
  • Anhedonia
  • Pain
  • Cholecystectomy
  • Emotional Distress
Drugs used concurrently:
  • Yasmin (Unk)
  • Loestrin 1.5/30 (Unk)
  • Ibuprofen
The patient was hospitalized. Although Errin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as injury, may still occur.

Musculoskeletal Pain, Abdominal Pain Upper, Anxiety, Arthralgia, Tendonitis, Influenza, Fatigue, Neck Pain, Musculoskeletal Chest Pain
This Musculoskeletal Pain, Abdominal Pain Upper, Anxiety, Arthralgia, Tendonitis, Influenza, Fatigue, Neck Pain, Musculoskeletal Chest Pain problem was reported by a physician from UNITED STATES. A 51-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: contraception,seasonal allergy,skin wrinkling. On Dec 07, 2010 this consumer started treatment with Errin (dosage: NA). The following drugs were being taken at the same time:
  • Allegra
  • Botox Cosmetic (24 Units, Single)
When commencing Errin, the patient experienced the following unwanted symptoms/side effects:
  • Musculoskeletal Pain
  • Abdominal Pain Upper
  • Anxiety
  • Arthralgia
  • Tendonitis
  • Influenza
  • Fatigue
  • Neck Pain
  • Musculoskeletal Chest Pain
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as musculoskeletal pain, may become evident only after a product is in use by the general population.

Pregnancy On Oral Contraceptive, Ectopic Pregnancy
This is a report of a 27-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: contraception and was treated with Errin (dosage: NA) starting Jun 01, 2010. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Pregnancy On Oral Contraceptive
  • Ectopic Pregnancy
The patient was hospitalized. This opens a possibility that Errin treatment could cause the above reactions, including pregnancy on oral contraceptive, and some female subjects may be more susceptible.


Gallbladder Injury
A female patient (weight: NA) from UNITED STATES with the following symptoms/conditions: NA started Errin treatment (dosage: Unk) on May 01, 2005. Soon after starting Errin treatment, the subject experienced various side effects, including:
  • Gallbladder Injury
Concurrently used drugs:
  • Norethindrone (Unk)
  • Clindamycin (60 G, Unk)
  • Doxycycline Hyclate (100 Mg, Unk)
  • Uncodeable ^unclassifiable^ (875 Mg, Unk)
  • Uncodeable ^unclassifiable^ (500 Mg, Unk)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Errin.

Cerebrovascular Accident, Depression, Dizziness, Gait Disturbance, Asthenia, Vertigo, Paraesthesia, Deep Vein Thrombosis, Headache
A female patient from UNITED STATES (weight: NA) experienced symptoms, such as: contraception and was treated with Errin(dosage: NA). The treatment was initiated on Jan 01, 2004. After that a consumer reported the following side effect(s):
  • Cerebrovascular Accident
  • Depression
  • Dizziness
  • Gait Disturbance
  • Asthenia
  • Vertigo
  • Paraesthesia
  • Deep Vein Thrombosis
  • Headache
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Errin efficacy:
  • Antibiotics
  • Acetaminophen (During Hospital Stay In Oct-2006)
  • Docusate Sodium W/sennoside A+b (During Hospital Stay In Oct-2006)
  • Lorazepam (During Hospital Stay In Oct-2006)
  • Synthroid
  • Yasmin
  • St Johns Wort
  • Trinessa (Unk)
The patient was hospitalized.

Constipation, Flatulence
In this report, Errin was administered for the following condition: contraception.A female consumer from UNITED STATES (weight: NA) started Errin treatment (dosage: .35mg 1 Daily Po) on Mar 01, 2009.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Constipation
  • Flatulence
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Errin treatment could be related to the listed above side effect(s).

Abdominal Pain, Alopecia, Headache, Nausea, Presyncope, Type 1 Diabetes Mellitus, Weight Decreased
This is a report of the following Errin side effect(s):
  • Abdominal Pain
  • Alopecia
  • Headache
  • Nausea
  • Presyncope
  • Type 1 Diabetes Mellitus
  • Weight Decreased
A 21-year-old female patient from UNITED STATES (weight: NA) presented with the following condition: contraception and received a treatment with Errin (dosage: 1 Per Day Po) starting: Jan 04, 2009.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Errin treatment could be associated with the listed above side effect(s).

Blood Glucose Decreased, Diabetic Coma, Road Traffic Accident
This Errin report was submitted by a 19-year-old female consumer from UNITED STATES (weight: NA). The patient was diagnosed with: contraception and Errin was administered (dosage: Daily Po) starting: Sep 05, 2008. The consumer developed a set of symptoms:
  • Blood Glucose Decreased
  • Diabetic Coma
  • Road Traffic Accident
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Errin treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Jaundice
This is a report of a possible correlation between Errin use and the following symptoms/side effect(s):
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
  • Blood Alkaline Phosphatase Increased
  • Jaundice
which could contribute to an assessment of Errin risk profile.A 31-year-old female consumer from UNITED STATES (weight: NA) was suffering from contraception and was treated with Errin (dosage: 1 Pill Daily Po) starting Oct 19, 2007.Other concurrent medications: NA.The patient was hospitalized.

Depression, Intentional Self-injury, Suicidal Ideation
A 29-year-old female patient from UNITED STATES (weight: NA) presented with the following symptoms: contraception and after a treatment with Errin (dosage: 1 Tablet 1 Per Day Po) experienced the following side effect(s):
  • Depression
  • Intentional Self-injury
  • Suicidal Ideation
The treatment was started on Aug 08, 2005. Errin was used in combination with the following drugs: NA.This report could alert potential Errin consumers.



Top 10 Errin Side Effects for Men

Men Side EffectsReports

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Errin Side Effects

    Did You Have a Errin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Errin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Errin Safety Alerts, Active Ingredients, Usage Information

    NDC0555-0344
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameErrin
    NameNorethindrone
    Dosage FormTABLET
    RouteORAL
    On market since20030108
    LabelerBarr Laboratories Inc.
    Active Ingredient(s)NORETHINDRONE
    Strength(s)0.35
    Unit(s)mg/1
    Pharma ClassProgesterone Congeners [Chemical/Ingredient],Progestin [EPC]

    More About Errin

    Side Effects reported to FDA: 11

    Errin safety alerts: 2014

    Reported hospitalizations: 6

    BCI Remote Alarm Cables By Smith's Medical ASD, Inc.: Class 1 Recall - Cables Are Not Transferring Alarms

     

    [Posted 04/09/2013]

    AUDIENCE: Risk Manager, Health Professional

    ISSUE: Smiths Medical has become aware that, in rare instances, the BCI Remote Alarm Cables (BCI Cables) are not transferring alarms when used with some remote nurse alarm systems. These products may cause serious adverse health consequences, including death.

    BACKGROUND: The BCI Remote Alarm Cables are designed for use with the 9004 Capnocheck Capnography (Plus or Sleep) System to transfer alarm signals from the Capnocheck Capnography System to a remote alarm system. The BCI Remote Alarm Cables and the 9004 Capnocheck Capnography System are intended for use in all critical environments including ventilator applications, patient transport, and anesthesia on patients ranging from pediatric to adult.

    RECOMMENDATION: On Feb. 6, 2013, Smiths Medical sent its customers an "Urgent Medical Device Field Safety Notice-Recall" letter by UPS and customers were instructed to:


    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

     

    [04/09/2013 - Recall Notice - FDA]

    Latest Errin clinical trials